Write what you believe about your stocks; every morning the cited record grades it: supported, challenged, or untouched. Never opinions.

Development · 10 Nov 2026

DIVISLAB, full dossier

Divi's Laboratories achieved a profit surge of 63.6% year-on-year for the September quarter of FY27, with operational revenue increasing by 35.4% to Rs 3,676 crore.

8 publishers have reported this development. Each act of reporting is below, cited.

The record

Divi's Laboratories achieved a profit surge of 63.6% year-on-year for the September quarter of FY27, with operational revenue increasing by 35.4% to Rs 3,676 crore.

indiatimes.com9 Nov 2026

Divi's Laboratories' consolidated net profit jumped nearly 64% year-on-year to ₹ 1,127 crore in the September quarter of FY27.

Divi's Laboratories Ltd posted a 63.57 per cent rise in net profit to ₹1,127 crore in the September quarter.

Divis Laboratories reported a 64% rise in Q2 net profit to Rs 1127 crore.

Divi's Laboratories reported a 64 percent year-on-year increase in its September quarter net profit.

Divi's Laboratories' consolidated net profit rose 64% year-on-year to ₹1,127 crore in Q2FY27, compared with ₹689 crore in the corresponding quarter of the previous fiscal year.

cnbctv18.com9 Nov 2026

Divi's Laboratories Ltd.'s net profit saw a 64% uptick to Rs 1,127 crore, according to the second quarter results for the fiscal 2026-27.

ndtvprofit.com7 Nov 2026

Divi's Laboratories

₹11,565.50

▲ +4.22%

Close (EOD), as of 9 Nov 2026 · source

Divi's Laboratories: results, dividends, orders, the full cited record →

Every claim carries its citation

This page is the corroborated record of one development: what each credible source reported, linked and dated. We compile and cite; we do not opine.

New here? The reader's guide explains every page, plate by plate.

fregime is informational research software. Content on this page is factual reporting compiled from cited public sources; nothing here is advice, and nothing here expresses an opinion on any security. fregime is not registered with SEBI as an investment adviser or research analyst. Before making investment decisions, consult a SEBI-registered adviser. Price figures are delayed end-of-day values cited to the exchange's published file, never live quotes.